NEW YORK - Up 38% in the last three months of 2001, the Russell 2000 Growth Index has sagged 12% so far this year. But William A. Muggia, co-manager of the Touchstone Emerging Growth Fund ($180 million assets), remains bullish on small and mid-cap growth companies, which he says are cheaper than those with large market values.
Quintiles Transnational (nasdaq: QTRN - news - people ), a clinical research and consulting services company for the drug, biotechnology and medical device industries, is one of Muggia's picks. He thinks the company has several items working in its favor, notably new management, recent cost-cutting measures, a likely increase in genomics-related research and the fact that several high-volume prescription drugs sold by rival firms are coming off patent.
Full story at Forbes.com